Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors
Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Studying Biomechanics of Circulating Cells by Modulating Their Electrodeformation Behavior
Published on: October 13, 2023
Reza Dastvan1, Smriti Mishra1, Yelena B Peskova2
1Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232, USA.
Abstract:
The ATP-binding cassette subfamily B member 1 (ABCB1) multidrug transporter P-glycoprotein plays a central role in clearance of xenobiotics in humans and is implicated in cancer resistance to chemotherapy. We used double electron electron resonance spectroscopy to uncover the basis of stimulation of P-glycoprotein adenosine 5'-triphosphate (ATP) hydrolysis by multiple substrates and illuminate how substrates and inhibitors differentially affect its transport function. Our results reveal that substrate-induced acceleration of ATP hydrolysis correlates with stabilization of a high-energy, post-ATP hydrolysis state characterized by structurally asymmetric nucleotide-binding sites. By contrast, this state is destabilized in the substrate-free cycle and by high-affinity inhibitors in favor of structurally symmetric nucleotide binding sites. Together with previous data, our findings lead to a general model of substrate and inhibitor coupling to P-glycoprotein.
Related Concept Videos
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Drug Absorption Mechanism: Passive Membrane Transport
Allosteric Regulation

